|
EDMONTON, ALBERTA--(Marketwired - July 7, 2016) - Ceapro Inc. (TSX VENTURE:CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and active ingredients for healthcare and cosmetic industries, is issuing this press release in response to a recent request by the Investment Industry Regulatory Organization of Canada ("IIROC") to comment on recent trading activity in its stock. |
